General Information of Disease (ID: DISN73RD)

Disease Name Varicella
Synonyms chicken pox; chicken pox infection; chickenpox; Varicella; varicella
Disease Class 1E90: Varicella
Definition
A contagious childhood disorder caused by the varicella zoster virus. It is transmitted via respiratory secretions and contact with chickenpox blister contents. It presents with a vesicular skin rash, usually associated with fever, headache, and myalgias. The pruritic fluid-filled vesicles occur 10-21 days after exposure and last for 3-4 days. An additional 3-4 days of malaise follows before the affected individual feels better. An individual is contagious 1-2 days prior to the appearance of the blisters until all blisters are crusted over. Generally, healthy individuals recover without complications.
Disease Hierarchy
DISV4VFZ: Vesiculobullous skin disease
DIS7U38D: Varicella zoster virus infection
DISFDJN8: Skin disorder caused by infection
DISN73RD: Varicella
ICD Code
ICD-11
ICD-11: 1E90
Disease Identifiers
MONDO ID
MONDO_0005700
MESH ID
D002644
UMLS CUI
C0008049
MedGen ID
2995
SNOMED CT ID
38907003

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 2 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Aciclovir DMYLOVR Approved Small molecular drug [1]
Valaciclovir DMHKS94 Approved Small molecular drug [2]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
GSK4178116A DM5ETIR Phase 2 Vaccine [3]
GSK4406371A DMGKKR9 Phase 2 Vaccine [3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Neonatal varicella. Arch Dis Child. 2023 Oct 31:archdischild-2022-324820.
2 Chickenpox. BMJ Clin Evid. 2011 Apr 11;2011:0912.
3 Clinical pipeline report, company report or official report of GlaxoSmithKline